Skip to main content

Dermata Therapeutics

Encinitas, United States

Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.

$2.0M raised
Mar 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dermata Therapeutics

How much funding has Dermata Therapeutics raised?
Dermata Therapeutics has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Who are Dermata Therapeutics's investors?
Dermata Therapeutics's investors include Silicon Valley Bank, Gerald Proehl, Kyri Van Hoose.
Where is Dermata Therapeutics headquartered?
Dermata Therapeutics is headquartered in Encinitas, United States.
What does Dermata Therapeutics do?
Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.
What stage is Dermata Therapeutics at?
Dermata Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dermata Therapeutics — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/dermata-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Dermata Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/dermata-therapeutics
Wikipedia (cite web)
{{cite web |title=Dermata Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dermata-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .